HoldsUp

FoundMyFitness · 2026-07-22 · Rhonda Patrick (host), Derya Unutmaz

Why the Next 10 Years May Add 50 to Your Lifespan | Dr. Derya Unutmaz

42 research-tied claims examined: 2 contradicted 3 overstated 4 context 29 supported 2 corroborated online 2 unverified

2

Contradicted by research

0:22:15Derya Unutmazcontradictedhigh

Humans did not have language until approximately 10,000 years ago, and writing and cognitive intelligence developed only in the last 10,000 to 20,000 years.

"We didn't have language up to, I don't know, 10,000 years ago; we didn't know how to write. This cognitive part has developed in the last maybe 10, 20,000 years." (said at 0:22:15)

The claim that humans did not have language until approximately 10,000 years ago and that cognitive intelligence only emerged in the last 10,000 to 20,000 years is contradicted by archaeological, paleoanthropological, and genetic consensus. Anatomically and cognitively modern *Homo sapiens* evolved over 100,000 to 300,000 years ago in Africa, displaying complex symbolic behavior, tool manufacturing, and language capacities tens to hundreds of thousands of years before the 10,000-year mark (for example, language and complex cognitive capacities were already established prior to human migrations out of Africa and the peopling of Australia at least 50,000 to 65,000 years ago). While the speaker's secondary mention that writing was absent prior to recent millennia is accurate (true writing systems first emerged around ~5,000 to 5,500 years ago in Mesopotamia and Egypt), spoken language and human cognitive capacities long predate the 10,000-to-20,000-year timeline.

1:10:55Derya Unutmazcontradictedhigh

Only about 1 in 5 to 1 in 10 people who take statins for high cholesterol derive a true cardiovascular benefit.

"we give statins to anyone who has high cholesterol. So I I think like one out of five or one out of 10 people truly benefit from that." (said at 1:10:55)

Large-scale systematic reviews and meta-analyses of randomized clinical trials show that for primary prevention of cardiovascular disease, statins reduce composite cardiovascular outcomes by an absolute risk difference (ARD) of approximately 1.28% over 1 to 6 years of follow-up (equating to roughly 1 in 78 individuals avoiding an event, or a Number Needed to Treat [NNT] of ~78). For myocardial infarction, the ARD is 0.85% (NNT ~118), and for all-cause mortality, it is 0.35% (NNT ~285). The claim that 1 in 5 (20%) to 1 in 10 (10%) individuals derive a true cardiovascular benefit substantially overestimates the absolute proportion of patients who avoid a major cardiovascular event over typical trial durations, which is closer to 1% to 2% (1 in 50 to 1 in 100).

Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.